VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $792,199,000 | -11.1% | 7,793,397 | +56.1% | 2.99% | -12.5% |
| Q3 2015 | $890,714,000 | -13.2% | 4,993,353 | +8.2% | 3.41% | -11.9% |
| Q2 2015 | $1,025,608,000 | +27.2% | 4,616,738 | +13.8% | 3.88% | +24.1% |
| Q1 2015 | $806,068,000 | -37.9% | 4,058,343 | -55.3% | 3.12% | -47.6% |
| Q4 2014 | $1,299,010,000 | -0.7% | 9,077,007 | -8.9% | 5.96% | +13.6% |
| Q3 2014 | $1,307,761,000 | -12.4% | 9,967,690 | -15.7% | 5.25% | -19.4% |
| Q2 2014 | $1,492,117,000 | +21.8% | 11,830,932 | +27.3% | 6.51% | +26.7% |
| Q1 2014 | $1,225,511,000 | +25.3% | 9,296,143 | +11.6% | 5.14% | +12.6% |
| Q4 2013 | $977,825,000 | +4.7% | 8,329,004 | -6.9% | 4.56% | -11.5% |
| Q3 2013 | $933,712,000 | +14.3% | 8,949,608 | -5.7% | 5.16% | +13.5% |
| Q2 2013 | $817,093,000 | – | 9,492,256 | – | 4.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |